Minerva Neurosciences, Inc: Minerva Neurosciences Reports Th

Company To Host Live Webcast Today at 8:30 a.m. ETBURLINGTON, Mass., Nov. 09, 2022(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous

Related Keywords

Fred Ahlholm , Helen Shik , Remy Luthringer , Minerva Neurosciences , Exchange Commission , Exchange Commission On , Shik Communications , Drug Administration , Minerva Neurosciences Inc , Nasdaq , Company To Host Live Webcast , Company To Host Live Webcast Today , New Drug Application , Executive Chairman , Chief Executive Officer , Interest Expense , Future Royalties , Royalty Pharma , Open Market Sale Agreement , Securities Act , Call Information , Private Securities Litigation Reform Act , Quarterly Report , Term Liabilities , Months Ended September , Aminerva , Neurosciences , Reports , Third , Quarter , 022 , Financial , Results , Business , Updates ,